1.
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
by Niewczas, Monika A
Nature medicine, 2019, Vol.25 (5), p.805-813
2.
Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
by Domingueti, Caroline Pereira
Journal of diabetes and its complications, 2015, Vol.30 (4), p.738-745
3.
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
by Leslie, R. David
Diabetologia, 2015, Vol.59 (1), p.13-20
4.
Periodontitis and diabetes: a two-way relationship
by Preshaw, P. M
Diabetologia, 2011, Vol.55 (1), p.21-31
5.
Type 2 diabetes
by Chatterjee, Sudesna, MD
The Lancet (British edition), 2017, Vol.389 (10085), p.2239-2251
6.
Diabetes in pregnancy: a new decade of challenges ahead
by Schaefer-Graf, Ute
Diabetologia, 2018, Vol.61 (5), p.1012-1021
7.
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
by Eid, Stephanie
Diabetologia, 2019, Vol.62 (9), p.1539-1549
8.
The many faces of diabetes: a disease with increasing heterogeneity
by Tuomi, Tiinamaija, MD
The Lancet (British edition), 2014, Vol.383 (9922), p.1084-1094
9.
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
by Zhang, Jie
Nature medicine, 2009, Vol.15 (8), p.940-945
10.
Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
by Peters, Anne L
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (11), p.3922-3937
11.
Molecular mechanisms of diabetic cardiomyopathy
by Bugger, Heiko
Diabetologia, 2014, Vol.57 (4), p.660-671
12.
Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
by Ohkuma, Toshiaki
Diabetologia, 2019, Vol.62 (9), p.1550-1560
13.
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
by Barzaghi, Federica Federica
Journal of allergy and clinical immunology, 2017, Vol.141 (3), p.1036-1049.e5
14.
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
by Kautzky-Willer, Alexandra
Endocrine reviews, 2016, Vol.37 (3), p.278-316
15.
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study
by Farzadfar, Farshad, MD
The Lancet (British edition), 2012, Vol.379 (9810), p.47-54
16.
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
by Sun, Lulu
Nature medicine, 2018, Vol.24 (12), p.1919-1929
17.
Diabetes and cognitive dysfunction
by McCrimmon, Rory J, Dr
The Lancet (British edition), 2012, Vol.379 (9833), p.2291-2299
18.
Prospective virome analyses in young children at increased genetic risk for type 1 diabetes
by Vehik, Kendra
Nature medicine, 2019, Vol.25 (12), p.1865-1872
19.
Development of SGLT1 and SGLT2 inhibitors
by Rieg, Timo
Diabetologia, 2018, Vol.61 (10), p.2079-2086
20.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
by Gæde, Peter
Diabetologia, 2016, Vol.59 (11), p.2298-2307
